Codexis, Inc. Announces $25M Public Offering of Common Stock

What Happened

• Codexis, Inc. (CDXS) announced on July 23, 2026 that it entered into an underwriting agreement with Piper Sandler & Co. and Cantor Fitzgerald & Co. The company sold 16,666,667 shares of common stock at $1.50 per share in an underwritten public offering, which closed on July 27, 2026. Gross proceeds were $25.0 million; net proceeds to the company were approximately $23.1 million after underwriting discounts, commissions and estimated offering expenses.

Key Details

• Offering size: 16,666,667 shares at $1.50 per share (gross proceeds $25.0M).
• Net proceeds: approximately $23.1 million after fees and expenses.
• Overallotment option: underwriters have a 30-day option to buy up to 2,500,000 additional shares.
• Lock-up: the company and its directors and executive officers agreed not to sell or transfer shares for 90 days after July 23, 2026, subject to customary exceptions.
• Documents: underwriting agreement and counsel opinion from Latham & Watkins LLP are filed as exhibits to the 8-K.

Why It Matters

• The offering provides Codexis with additional liquidity (about $23.1M net) which can be used for operations, R&D, or other corporate needs. The overallotment option could increase dilution if exercised. The 90-day lock-up restricts insider selling in the short term, which can help stabilize the stock following the offering. Investors should factor in the increase in outstanding shares and potential dilution when assessing near-term per-share metrics.